An engineered platform for controllable, “cell-activated” therapeutic delivery.

An engineered platform for controllable, “cell-activated” therapeutic delivery.
Use of short/medium chain fatty acids, including valerate and bile salt hydrolase (BSH) for the treatment and prevention of recurrent C. difficile infection.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean nec venenatis arcu. In fermentum non tellus nec vulputate. Integer accumsan, nunc sit amet porta commodo, diam sapien feugiat purus, at imperdiet arcu nisi quis dui. Etiam vel nisl sem. Proin felis nisl, fringilla eu eros ac, sodales pellentesque sem.